Stocksigma LogoStocksigma Logo

Astal Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 10,794 (+187.7% YoY | +6.9% QoQ) ■ EBITDA: 1,729 (+347.0% YoY | +41.2% QoQ) ■ EBITDA Margin (%): 16.0 (+571 bps YoY | +389 bps QoQ) ■ PAT: 977

Astal Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Astal Laboratories Ltd · Outcome · 14 Nov 2026, 1:27 am

Astal Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 10,794 (+187.7% YoY | +6.9% QoQ) ■ EBITDA: 1,729 (+347.0% YoY | +41.2% QoQ) ■ EBITDA Margin (%): 16.0 (+571 bps YoY | +389 bps QoQ) ■ PAT: 977 (+278.3% YoY | +3.7% QoQ) ■ EPS (INR): 2.22 (+12.6% YoY | +2.0% QoQ)

Original exchange filing (PDF)

More announcements from Astal Laboratories Ltd

All Astal Laboratories Ltd announcements